))
Markus Zohner Arts Company is based in Lugano / Switzerland. The company produces Theatre Performances, Arts Projects, Podcast- and Radio Shows, offers trainings in Theatre, Creativity and Comunication, realizes Exhibitions and tours around the world. La Markus Zohner Arts Company ha sede a Lugano / Svizzera. La Compagnia produce spettacoli teatrali, progetti artistici, podcast, offre masterclasses per teatranti, realizza esposizioni, mostre fotografiche e multimediali e con le sue produzion ...
Travel Made Easy!
Life before, during and after the holocaust with Buchenwald survivor, Melvin Federbush. In hour 5 of this series, he reveals his harrowing experiences while in Nazi occupied Poland. Melvin Federbush was born in Deblin, Poland, July 1923. He attended Cheder and Yeshiva as well as high school. Within eight days of Hitler's invasion of Poland, his parents and nine year old twin sisters were killed during a bombing attack. Melvin was taken prisoner during the Nazi occupation and forced to live i ...
Broadcasting the latest developments in GU cancer
// LE CATALYSTE // "A Catalyst is a substance that causes or accelerates a chemical reaction." The purpose of the show is to bring together younger and older generations and people from various origins or styles showing how vast and rich is the culture and the history of the electronic music. "Le Catalyste" is weekly infused Podcast. At the begining, it was a French speaking radio show presented by Vince Kuzanagi on CKUM FM in Canada. While moving to France, it is temporarily turned into a p ...
Stefano Capasso is an international Dj and Producer. He starts his career working with Claudio Casalini and Claudio Donato. From "Riviera Romagnola" to Rome his set will become famous for the happy sound, the quality and the variety of his music (House, Soulful, Tech House and Disco Music often). Over the years divided the console with Dave Morales, Frankie Knuckles, Jamie Lewis, Martin Solveig, Carl Craig...Its main achievements: "Cadillac Car" (Purple Music) also remixed by Jamie Lewis, "C ...
son:DA belogs to that area of art characterised by linking of various technologies and media, as well as a new approach to the group work. son:DA is active in the fields of space installations, computer drawings, audio-video performances and different gallery project. Since 2000 son:DA has shown their work internationaly.Their solo exhibition were in Razstavnem salonu Rotovž Maribor, Kibla Maribor, Galeriji Meduza Koper, Likovnem salonu Celje, Galerij Kapelica Ljubljana, ARCO Madrid, Turner ...
T
The Uromigos
1
Episode 73: The Uromigos meet APCCC in a discussion on oligometastatic prostate cancer @APCCC_Lugano
25:11
25:11
Play later
Play later
Lists
Like
Liked
25:11
Piet Ost, Chris Sweeney and Silke Gillessen discuss controversies around the management of oligometastatic prostate cancer.
T
The Uromigos
1
Episode 75: The Uromigos meet APCCC - bone health and bone disease in prostate cancer with Bertrand Tombal
25:47
25:47
Play later
Play later
Lists
Like
Liked
25:47
Silke, Chris and Bertrand discuss bone protective therapy and bone targeted therapy.
T
The Uromigos
1
Episode 74: The Uromigos meet APCCC Round 2: First line treatment - low vs high volume; chemo vs abi/enza
32:05
32:05
Play later
Play later
Lists
Like
Liked
32:05
Nick James and Chris Sweeney debate this issue. Tom and Silke try to keep things on track.
T
The Uromigos
1
Episode 72: Uromigos Christmas Special - Renal cancer year in review
24:25
24:25
Play later
Play later
Lists
Like
Liked
24:25
Laurence Albiges discusses renal cancer highlights from the year.
T
The Uromigos
1
Episode 71: Bladder Cancer Uromigos Christmas Special with Matt Galsky
24:57
24:57
Play later
Play later
Lists
Like
Liked
24:57
Matt discusses the year in review, including first line and adjuvant immune therapy studies, ADCs and FGFR targeting are also discussed.
T
The Uromigos
1
Episode 70: The Uromigos Prostate Cancer Christmas Special with Chuck Ryan
25:56
25:56
Play later
Play later
Lists
Like
Liked
25:56
A review of the year in prostate cancer with Chuck Ryan.
T
The Uromigos
1
Episode 69: Testis Cancer Christmas Special: 2020 year in review
25:16
25:16
Play later
Play later
Lists
Like
Liked
25:16
Christian Kollmannsberger gets into the Christmas spirit by discussing highlights of 2020.
T
The Uromigos
1
Episode 68: Uromigos Paper of the Month - a molecular classification of renal cancer in Cancer Cell
26:24
26:24
Play later
Play later
Lists
Like
Liked
26:24
Kim Rathmell discusses this paper, which divides clear cell renal cancer into seven relevant subgroups. Brian askes an interesting question at one point.
T
The Uromigos
1
Episode 67: The Third Uromigos Debate - PD1/VEGF vs PD1/CTLA4 for front line renal cancer
28:48
28:48
Play later
Play later
Lists
Like
Liked
28:48
David McDermott and Brian Rini debate treatment options in front line renal cancer. It's hard to identify any winners from this podcast.
T
The Uromigos
1
Episode 66: Uromigos Paper of the Month - Two papers in Nature Medicine on neoadjuvant immune combinations in bladder cancer
30:49
30:49
Play later
Play later
Lists
Like
Liked
30:49
Pam Sharma and Michiel Van Der Heijden discuss neoadjuvant PD(L)1 + CTLA4 inhibition in urothelial cancer.
T
The Uromigos
1
Episode 65: Review of the International Kidney Cancer Symposium
22:31
22:31
Play later
Play later
Lists
Like
Liked
22:31
Gretchen Vaughan, Kidney Cancer Association CEO, discusses the upcoming International Kidney Cancer Symposium meeting and KCA's grant program. Tom and Brian review some of the top abstracts.
T
The Uromigos
1
Episode 64: The Second Uromigos debate with Nobel Laureate Bill Kaelin on new biomarker vs new drugs in RCC
28:57
28:57
Play later
Play later
Lists
Like
Liked
28:57
'New Drugs vs New Biomarkers' Bill Kaelin (Nobel Laureate) vs Tom Powles (keen cyclist), extend their discussion from KCRS20 in the 2nd Uromigos Debate.
l
le Catalyste radio show
1
Vince Kuzanagi : Dark Melody Of Rain - ECU 10/2020 - Intelligent Techno Event
1:00:44
1:00:44
Play later
Play later
Lists
Like
Liked
1:00:44
From podcasts to live recordings, 24 HOURS OF MUSIC over the week-end that the world can enjoy at its best moment.Alongside Urko, Romain Richard, Mike Storm, Errorbeauty,Dimitar Georgiev,Cardioactive,Markov,Human Koala,Octal Industries,Cyan341,c0ma,E M P T Y,Feryne,Jack Dover,Lenny Posso,Mike Griffin,Kerim Bey,SideChange,2OHM,Zadig,Fik, St…
T
The Uromigos
1
Episode 63: The First Uromigos Debate: front line immune therapy vs maintenance avelumab in bladder cancer
21:19
21:19
Play later
Play later
Lists
Like
Liked
21:19
Dr. Peter O'Donnell and Prof. Tom Powles debate front line treatment options in urothelial cancer.
T
The Uromigos
1
Episode 62: James Eastham's Uromigos Paper of the Month - Prostatectomy +/- Neoadjuvant Chemo
27:44
27:44
Play later
Play later
Lists
Like
Liked
27:44
A large randomised investigator-initiated Alliance study gives insight in to perioperative treatments for high risk prostate cancer.
l
le Catalyste radio show
1
Standalone series: ADJ (Pyramid Transmissions - UK)- Electro / breaks
1:56:08
1:56:08
Play later
Play later
Lists
Like
Liked
1:56:08
This week, Le Catalyste is proud to resume and open its Fifth year with a true underground electronic Music Activist : ADJAndy Jaggers is a DJ, Producer, Label owner (Pyramid Transmissions Record), Events and club runner, radio show presenter. He was also records shop Owner at IQ records in the 90's !!As a DJ, he has played at many festivals and cl…
T
The Uromigos
1
Episode 61: Nick James discusses the latest update of the STAMPEDE study
17:16
17:16
Play later
Play later
Lists
Like
Liked
17:16
Nick gives us a quick summary of the STAMPEDE study and gives an overview of the latest data.
T
The Uromigos
1
Episode 60: Cora Sternberg discusses AMG 160 - a bispecific antibody in prostate cancer
14:58
14:58
Play later
Play later
Lists
Like
Liked
14:58
AMG 160; a half-life extended (HLE) bispecific T-cell engager (BITE®) antibody construct is discussed as is the future of immune therapy in CRPC.
T
The Uromigos
1
Episode 59: Ipatercertib in biomarker positive castrate resistant prostate cancer
25:33
25:33
Play later
Play later
Lists
Like
Liked
25:33
Chris Sweeney (last author) discusses the ATK inhibitor Ipatercertib in pTEN altered CRPC. A positive R3 trial in the ESMO plenary session.
T
The Uromigos
1
Episode 58: Brilliant ESMO discussant Richard Cathomas talks to Brian and Tom about the meaning of DANUBE and KN362
26:44
26:44
Play later
Play later
Lists
Like
Liked
26:44
The group go into the detail of chemo immune combinations and what to do next.
T
The Uromigos
1
Episode 57: Toni Choueiri - cabo & nivo vs sunitinib in metastatic clear cell renal cancer
26:12
26:12
Play later
Play later
Lists
Like
Liked
26:12
The group attempts to put the data into context with the other available combinations.
T
The Uromigos
1
Episode 56: Matt Galsky and Tom Powles discuss ESMO 2020 immune therapy data in bladder cancer
27:40
27:40
Play later
Play later
Lists
Like
Liked
27:40
The group try to get to the bottom of whether these data has made any difference in treatment and future plans.
T
The Uromigos
1
Episode 55: The Uromigos Paper of the Month - Cabozantinib in Bladder Cancer by Dr. Andrea Apolo
23:26
23:26
Play later
Play later
Lists
Like
Liked
23:26
Andrea talks about her phase 2 trial which shows activity for Cabozantinib in urothelial cancer.
l
le Catalyste radio show
1
Vince Kuzanagi : My robots library - ECU 08/2020
1:30:00
1:30:00
Play later
Play later
Lists
Like
Liked
1:30:00
Old School electronica Set . made by Vince Kuzanagi for ECU event 08/2020https://mixlr.com/ecuInfinite thanks to Florence at @moicflo and EC Underground http://www.ecunderground.com/Tracklist:1 - Kenny Larkin - Tedra - Azimuth - Warp2 - Lawrel - Fireflies - Fireflies - inclusif 0043 - Iron Curtis - A1. 010103 - And The Temper - Office Recordings4 -…
T
The Uromigos
1
Episode 54: Biomarkers in prostate cancer with Chris Sweeney
25:05
25:05
Play later
Play later
Lists
Like
Liked
25:05
Some thought it would never come - the final podcast of the World Tour from Boston.
T
The Uromigos
1
Episode 53: Still in Boston - biomarkers in bladder cancer
18:43
18:43
Play later
Play later
Lists
Like
Liked
18:43
Tom, Brian and Chris Sweeney discuss the challenges of development of biomarkers for immune therapy in bladder cancer.
T
The Uromigos
1
Episode 52: The Final Stop - Boston: David McDermott discusses biomarkers in renal cancer in the era of immune therapy
20:01
20:01
Play later
Play later
Lists
Like
Liked
20:01
Tom, David and Brian discuss biomarkers in renal cancer in the era of immune therapy.
T
The Uromigos
1
Episode 51: The Uromigos World Tour is in Norway with Jan Oldenburg - discussing key topics in testis cancer
22:52
22:52
Play later
Play later
Lists
Like
Liked
22:52
Jan Oldenburg from Norway discusses treatment choices for stage 1 testis cancer, the dilemma of high dose therapy for relapse and long term toxicity of chemotherapy.
T
The Uromigos
1
Episode 50: The Uromigos World Tour in London with renal cancer surgery
22:53
22:53
Play later
Play later
Lists
Like
Liked
22:53
Axel Bex talks about small renal masses, robotic vs partial nephrectomy and surgery in metastatic disease.
T
The Uromigos
1
Episode 49: The Tour remains in Germany with Oliver Grimm and renal cancer
22:15
22:15
Play later
Play later
Lists
Like
Liked
22:15
The World Tour stays in Germany to discuss the first line renal cancer (clear cell and non-clear cell) and clinical trials with Oliver Grimm.
T
The Uromigos
1
Episode 48: ...and then Germany - Jürgen Gschwend discusses cystectomy for urothelial cancer
20:38
20:38
Play later
Play later
Lists
Like
Liked
20:38
Jürgen discusses German research and surgery for bladder cancer. The podcast ends abruptly - which was not his fault!
T
The Uromigos
1
Episode 46: The Uromigos World Tour in Spain discussing SOGUG and Renal Cancer with Cristina Suarez
19:38
19:38
Play later
Play later
Lists
Like
Liked
19:38
Cristina Suarez discusses the success of clinical trials in Spain, and access to treatments.
T
The Uromigos
1
Episode 45: The Uromigos World Tour arrives in Japan
20:29
20:29
Play later
Play later
Lists
Like
Liked
20:29
Yoshi Tomita explains treatment pathways and research in GU cancer in Japan. Brian explains why he likes Japan so much.
T
The Uromigos
1
Episode 44: The Uromigos World Tour in Australia - Talking with Ian Davis about prostate cancer and ANZUP
31:51
31:51
Play later
Play later
Lists
Like
Liked
31:51
Ian Davis discusses why ANZUP has been so successful, and the EnzaMet study. An uninvited guest arrives towards the end.
T
The Uromigos
1
Episode 43: The Uromigos World Tour in Singapore with Ravi Kanesvaran
18:20
18:20
Play later
Play later
Lists
Like
Liked
18:20
Ravi describes treatment pathways and research for Southeast Asia in GU cancer.
Juan Sade discusses research, treatment pathways in GU cancer, steak and red wine in Argentina.
T
The Uromigos
1
Episode 41: The Uromigos World Tour lands in Brazil - Fernando Maluf talks about prostate cancer and recent research in Brazil
24:04
24:04
Play later
Play later
Lists
Like
Liked
24:04
The tour lands in sunny Brazil with a trip to a Japanese restaurant and a discussion about research and prostate cancer.
T
The Uromigos
1
Episode 40: The Uromigos World Tour moves to France - Bernard Escudier discusses 2nd line therapy in renal cancer and Tivozanib
20:02
20:02
Play later
Play later
Lists
Like
Liked
20:02
The Uromigos World Tour moves to Paris. Treatment for tumours that progress after first line immunetherapy is discussed. The role of Tivozanib is a focus for the dialogue.
T
The Uromigos
1
Episode 39: The Uromigos World Tour - Renal Cancer and IMDC Risk with Danny Heng in Calgary
20:17
20:17
Play later
Play later
Lists
Like
Liked
20:17
Danny discusses Italian food and the past, present and future of the IMDC prognostic score.
T
The Uromigos
1
Episode 38: The Uromigos Virtual World Tour - starting in Vancouver with Atezolizumab in NMIBC
20:21
20:21
Play later
Play later
Lists
Like
Liked
20:21
Peter Black talks about his recent BCG refractory NMIBC ASCO presentation and its implications for the field.
T
The Uromigos
1
Episode 37: Regoratinib (FGFR inhibitor) and Atezolizumab in UC with Jonathan Rosenberg
18:11
18:11
Play later
Play later
Lists
Like
Liked
18:11
Everything you wanted to know about FGFR inhibition but were afraid to ask.
T
The Uromigos
1
Episode 36: Dr. Tian Zhang discusses three ASCO bladder cancer abstracts with immune therapy/targeted therapy combinations
20:58
20:58
Play later
Play later
Lists
Like
Liked
20:58
Tian Zhang discusses three ASCO bladder cancer abstracts with immune therapy/targeted therapy combinations
T
The Uromigos
1
Episode 35: Maintenance Avelumab in Bladder Cancer (LBA1)
17:41
17:41
Play later
Play later
Lists
Like
Liked
17:41
Dr. Kala Sridhar, Professor Tom Powles and Dr. Brian Rini discuss the data presented at ASCO.
T
The Uromigos
1
Episode 34: Savolitinib in Renal Papillary Cancer - A Major Breakthrough?
20:40
20:40
Play later
Play later
Lists
Like
Liked
20:40
Dr. Toni Choueiri discusses the results of this study, which appears to show a survival signal, but it is difficult to interpret.
T
The Uromigos
1
Episode 33: Adjuvant Atezolizumab in Urothelial Cancer
19:59
19:59
Play later
Play later
Lists
Like
Liked
19:59
Joaquim Bellmunt explains a bit about why this trial was not successful and what it means for the field.
T
The Uromigos
1
Episode 32: A Phase 2 Study of PSMA PET in Prostate Cancer with Thomas Hope from ASCO 2020
24:09
24:09
Play later
Play later
Lists
Like
Liked
24:09
Thomas Hope is quizzed on the results of his study presented at ASCO20.
T
The Uromigos
1
Episode 31: A Phase 2 Study of Nivolumab with the Addition of Ipilimumab Upon Progression in Renal Cancer
25:18
25:18
Play later
Play later
Lists
Like
Liked
25:18
Mike Atkins describes the results of this study which helps shed light on the role of ipilimumab and nivolumab in this disease.
T
The Uromigos
1
Episode 30: Update on Axitinib plus Pembrolizumab in Renal Cancer (KEYNOTE 426)
20:03
20:03
Play later
Play later
Lists
Like
Liked
20:03
Betsy Plimack discusses the updated data with a minimum of 23 months' follow up. Dr. Brian Rini and Professor Tom Powles asks what it adds.
T
The Uromigos
1
Episode 29: PSMA PET at ASCO 2020 with Mike Morris
23:47
23:47
Play later
Play later
Lists
Like
Liked
23:47
Mike Morris presents the findings in his prospective study.
T
The Uromigos
1
Episode 28: Targeting VHL Syndrome Renal Cancer with a HIF Inhibitor - A Game Changer
13:31
13:31
Play later
Play later
Lists
Like
Liked
13:31
Eric Jonasch discusses his ASCO presentation, which shows significant activity of HIF targeting in renal cancer patients with VHL syndrome.
